These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8964808)

  • 1. Endothelin-mediated vascular tone following focal cerebral ischaemia in the cat.
    Patel TR; Galbraith S; McAuley MA; McCulloch J
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):679-87. PubMed ID: 8964808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
    Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-B receptors in cerebral resistance arterioles and their functional significance after focal cerebral ischemia in cats.
    Touzani O; Galbraith S; Siegl P; McCulloch J
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1157-65. PubMed ID: 9390647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist.
    Patel TR; McAuley MA; McCulloch J
    Eur J Pharmacol; 1994 Jul; 260(1):65-71. PubMed ID: 7794420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile responses to endothelin in feline cortical vessels in situ.
    Robinson MJ; McCulloch J
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):285-9. PubMed ID: 2406278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists.
    Edvinsson L; McCulloch J; Sharkey J
    Br J Pharmacol; 1985 Jun; 85(2):403-10. PubMed ID: 3896363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo.
    Patel TR; McAuley MA; McCulloch J
    Eur J Pharmacol; 1996 Jun; 307(1):41-8. PubMed ID: 8831102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ.
    Edvinsson L; Emson P; McCulloch J; Tatemoto K; Uddman R
    Acta Physiol Scand; 1984 Oct; 122(2):155-63. PubMed ID: 6549101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of potassium and pH on the calibre of cerebral veins and arteries.
    McCulloch J; Edvinsson L; Watt P
    Pflugers Arch; 1982 Mar; 393(1):95-8. PubMed ID: 7088689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of endothelin receptor antagonists in experimental stroke.
    Patel TR; Galbraith SL; McAuley MA; Doherty AM; Graham DI; McCulloch J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S412-5. PubMed ID: 8587430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats.
    Harper AM; MacKenzie ET
    J Physiol; 1977 Oct; 271(3):735-46. PubMed ID: 926021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholecystokinin octapeptide on pial arteriolar diameter.
    McCulloch J; Kelly PA
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):625-8. PubMed ID: 6094602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine of pial arteriolar calibre: an in vivo study.
    Brandt L; Andersson KE; Bengtsson B; Edvinsson L; Ljunggren B; MacKenzie ET
    Surg Neurol; 1979 Nov; 12(5):349-52. PubMed ID: 515931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor effects of atrial natriuretic peptides on feline pial arterioles.
    Macrae IM; Graham DI; McCulloch J
    Brain Res; 1987 Dec; 435(1-2):195-201. PubMed ID: 2962699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cortical ischaemic penumbra associated with occlusion of the middle cerebral artery in the cat: 1. Topography of changes in blood flow, potassium ion activity, and EEG.
    Strong AJ; Venables GS; Gibson G
    J Cereb Blood Flow Metab; 1983 Mar; 3(1):86-96. PubMed ID: 6822624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat.
    Bhardwaj A; Wu Y; Hurn PD; Kirsch JR; Traystman RJ
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):499-504. PubMed ID: 10724114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.
    Cao S; Wang LC; Kwansa H; Roman RJ; Harder DR; Koehler RC
    Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1412-8. PubMed ID: 19261918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat.
    Sharkey J; Ritchie IM; Kelly PA
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):865-71. PubMed ID: 8360292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral circulation and histamine: 2. Responses of pial veins and arterioles to receptor agonists.
    Gross PM; Harper AM; Teasdale GM
    J Cereb Blood Flow Metab; 1981; 1(2):219-25. PubMed ID: 6460043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of perfluorochemicals on experimental cerebral ischemia].
    Yamashita K; Yamaguchi S; Kobayashi S
    No To Shinkei; 1989 Dec; 41(12):1205-10. PubMed ID: 2627538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.